Discover 4-Chloro-3-Nitro-5-Sulfamoylbenzoic Acid: Your Key Bumetanide Synthesis Intermediate
High-purity pharmaceutical intermediate essential for Bumetanide production. Reliable sourcing for your manufacturing needs.
Get a Quote & SampleProduct Core Value
4-Chloro-3-Nitro-5-Sulfamoylbenzoic Acid
This critical pharmaceutical intermediate is vital for the effective synthesis of Bumetanide, a widely used diuretic. We ensure consistent quality and purity for your advanced chemical synthesis needs.
- Leverage our expertise in bumetanide synthesis intermediate production to streamline your manufacturing processes.
- Source high purity pharmaceutical intermediate with confidence, backed by GMP, ISO 9001, and FDA certifications.
- Benefit from a reliable supplier for CAS 22892-96-2 chemical, ensuring consistent quality for your projects.
- Explore custom synthesis pharmaceutical intermediate options tailored to your specific requirements with our experienced team.
Advantages You Gain
Uncompromised Purity
Achieve superior results in your bumetanide synthesis intermediate processes with our product, boasting purity greater than 98%.
Quality Assurance
Our commitment to quality is reflected in our certifications: GMP, ISO 9001, and FDA compliance, ensuring a dependable pharmaceutical intermediate supplier.
Seamless Integration
The consistent quality of our CAS 22892-96-2 chemical allows for seamless integration into your existing pharmaceutical manufacturing workflows.
Key Applications
Bumetanide Synthesis
This intermediate is fundamental for the production of Bumetanide, a potent diuretic used to treat fluid retention and swelling associated with various medical conditions.
Pharmaceutical Manufacturing
Essential building block in the pharmaceutical industry for the creation of active pharmaceutical ingredients (APIs), ensuring the efficacy and safety of the final drug product.
Chemical Synthesis
Beyond pharmaceuticals, its unique chemical structure makes it valuable in broader organic synthesis applications where precise molecular design is required.
Research & Development
Supports R&D efforts in developing new therapeutic agents or optimizing existing synthesis routes, aiding in the advancement of medicinal chemistry.